Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis
The American Journal of the Medical Sciences, 01/14/2011
Evidence Based Medicine
Stavrakis S et al. – The role of low–dose aspirin for primary prevention of cardiovascular events in patients with diabetes remains unproven, and its routine use cannot be justified at present. More trials are needed to definitively address this issue.